Galaxy Laboratories Pvt. Ltd. (GLPL) began as a VC-backed initiative in 1991.
Mission—to make India’s pharmaceutical ecosystem more self-reliant by producing high-purity, optimum yield API intermediate as import substitutes. 

‍What began with just 2 organic compounds—Furfurylamine and 2,4-Dichloroacetophenone—has since evolved into a diverse product portfolio, including agrochemical intermediates supporting crop science and agricultural biodiversity. Guided by the expertise of Mr. Shrikant Deshmukh, whose strategic techno-economic decisions powered our growth, Galaxy Laboratories is today a fully independent entity and an acclaimed name in API intermediate manufacturing. 

Over the past 3 decades, we have established dedicated R&D facilities and integrated continuous manufacturing production lines at 2 sprawling setups—one at Chhatrapati Sambhajinagar and the other at Newasa in Maharashtra, India. Our emphasis on quality, compliance, and sustainability has earned us global recognition as a trusted API intermediate Manufacturing Company. We work with a client-first approach, exceptional agility, and absolute transparency. 

‍Operating from GMP-ISO certified facilities, GLPL brings data-driven innovation, process robustness, production excellence, and supply chain efficiency to every project. Our emphasis on quality, compliance, and sustainability has earned us global recognition as an API Intermediate manufacturer. Galaxy Laboratories continues to nurture strong partnerships with leading multinational pharma, cosmetic, perfumery, agrochemical, and specialty chemical companies.